WSNS News
FDA MedWatch - UPDATE: CT Brain Perfusion Scans Safety Investigation - Additional cases of excess radiation exposure, recommendations provided. More
FDA MedWatch: Plavix and Prilosec Drug Interaction
The FDA released new data showing that the effectiveness of clopidogrel is reduced when clopidogrel and omeprazole are taken together. Read more
FDA MEDWATCH: CT Brain Perfusion Scans Safety Investigation: Initial Notification
[Posted 10/09/2009] FDA notified healthcare professionals that it has become aware of radiation overexposures during perfusion CT imaging performed to aid in the diagnosis of stroke at a particular facility, the patients receiving radiation doses that were approximately eight times the expected level. While this event involved a single kind of diagnostic test at one facility, the magnitude of these overdoses and their impact on the affected patients were significant. Read more
FDA MEDWATCH: Natalizumab - FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) More
CMS Announces Proposed Changes to the Medicare Physician Fee Schedule (From Dale Overfield, MD, WSNS ex officio board member for AAN NeuroCAC*) See page 3 of the linked document regarding proposed changes in reimbursement for specialists.
*Note: Carrier Advisory Committees (CACs) help Medicare carriers implement policies and provide physicians with a voice at the local level. The committees meet approximately three times per year to discuss Medicare policy and comment on proposed language for Medicare carrier local coverage decisions (LCDs) that affect physician reimbursement.To learn more about the NeuroCAC, click here. |
 |
Save The Date!
WSNS Events
|
| |
|
 |
WSNS Leadership |
| |
|
WSNS PURPOSE
The purpose of this Society shall be:
- To promote the science and practice of neurology in Washington State;
- To advocate for neurologists and patients with neurologic disorders;
- To promote and protect the neurologic health of the public. |
|
